Genetic screening, both before and during pregnancy, can help to identify when there may be an increased risk of certain genetic conditions. The CARE program can guide patients through the screening process and facilitate testing. Patients and providers can work together to use the results delivered through CARE to personalize family planning as well as pre- and postnatal care. With CARE, there is support for patients and providers at every step.
Screening Tests
The American College of Medical Genetics and Genomics (ACMG) recommends an approach to carrier screening and NIPT that is guided by informed decision-making. The CARE program supports informed decision-making through access to education and genetic counseling. Our screening test menu is based on guidance from the American College of Obstetrics and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG).
Carrier Screening
Carrier screening can be used to clarify the chance for a couple to have a baby with certain genetic conditions, even if they do not have personal or family histories of the conditions themselves. Examples of genetic conditions that may be screened for include cystic fibrosis (CF) and spinal muscular atrophy (SMA). Most people are carriers of differences in genes that do not affect health, but when passed to children in combination with similar differences from their partners, can lead to a child having a genetic condition.
Anyone who is interested in having biological children in the future or who is currently pregnant can consider carrier screening, individually or together with a partner. The CARE Program can be used to educate patients on carrier screening, deliver test results, facilitate partner testing, and connect patients with pre-and post-test genetic counseling.
Non-invasive Prenatal Testing (NIPT)
Non-invasive prenatal testing (NIPT), also known as noninvasive prenatal screening (NIPS), examines DNA from the placenta that can be found in a pregnant person’s blood. The test screens for certain chromosomal conditions, such as Down syndrome, and can be performed as early as 10 weeks into pregnancy.
Anyone who is pregnant can consider NIPT. The CARE Program can be used to educate patients on NIPT, deliver test results (including predicted fetal sex, if available), and connect patients with pre- and post-test genetic counseling.
Providers
Consistently offer guideline-recommended reproductive health screening
Enable patient education, informed consent, and connection to genetic counseling
Identify high-risk couples or pregnancies to empower personalized care
Streamline patient and partner testing and automate sensitive result delivery for efficient clinic workflows
Patients
Access resources to better understand your reproductive health screening options
Speak with a genetic counselor to discuss your genetic testing options and results
Customize family planning and prenatal care
How Does CARE Work?
A seamless solution for identifying the most at-risk patients.
Identification
Using digital tools to collect/analyze patient health data
Pre-Test Education
Demonstrating how genetic testing can guide health and family planning and prenatal care
Genetic Testing
Streamlining ordering through Ambry for qualified individuals
Results Delivery
Delivering results to the ordering provider and next steps for patients, including customizable options for patient result disclosure
Post-Test Genetic Counseling
Making counseling available by telehealth to all patients who have testing, at no charge to patient
Documentation
Improving patient and provider experience with transparency at each step